Epigenetic regulation of Cereblon in cancer: molecular mechanisms and clinical implications
{{output}}
Background: Cereblon (CRBN) serves as the substrate recognition subunit of the CRL4-CRBN E3 ubiquitin ligase complex and isthe primary target of immunomodulatory drugs (IMiDs) in cancer therapy. While CRBN mutations occur infrequ... ...
